$IVOB’s IVF Treatment Could Be a Solution to Population Problems
November 23rd, 2009 at 7:28 am Posted by The Dean
When people think about infertility, many might see only the female part of the equation. But, according to the Human Fertilisation and Embryology Authority (HFEA), infertility affects 1 in 6, or 17%, of European couples and male factors contribute to 40% of the cases.
An article from BBC News suggests that poor sperm motility is one of the most common fertility problems in men. Some in the medical and research communities also attribute DNA damage to the sperm as “a major cause of male infertility.”
So how does more infertility help an infertility treatment company like $IVOB? The Dean believes that’s simple. There’s estimated to be at least 150 million infertile couples in the world and, in time, more causes of infertility could increase the number of infertile couples seeking infertility treatment.
With an increasing number of infertile couples all over the world, $IVOB’s INVO procedure could be chosen as an IVF treatment more often, generating more revenues.
The Dean believes there is a genuine need for infertility treatments, especially because a report from Medical News Today confirms that birth rates have declined 29% over the past 50 years from 2.1 children per couple to 1.5 births per woman. That figure is only expected to increase 6% to 1.6 births per woman in the next 20 years.
The Dean believes that in some parts of the world entire populations are being affected by infertility. In fact, last year the European Parliament for the first time acknowledged that failing fertility rates were a major cause of demographic decline.
And even more convincing is that researchers claim that infertility has officially outweighed mortality and migration as a determinant for Europe’s future population.
Certainly, The Dean sees potential for $IVOB’s INVO procedure in many parts of the world, but, at least at this point in time, $IVOB’s infertility treatment has CE Mark approval and can be used in Europe.
